Underestimation of Cutaneous Squamous Cell Carcinoma Incidence, Even in Cancer Registries-Reference-Cited by-同舟云学术

Underestimation of Cutaneous Squamous Cell Carcinoma Incidence, Even in Cancer Registries

Published:2020-12-01 Issue:12 Volume:156 Page:1290
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Wehner Mackenzie R.¹²

Affiliation:

1. Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston

2. Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2771923/jamadermatology_wehner_2020_ed_200018_1607046258.06398.pdf

Reference6 articles.

1. A systematic review of worldwide incidence of nonmelanoma skin cancer.;Lomas;Br J Dermatol,2012

2. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.;Flohil;Eur J Cancer,2013

3. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.;Wehner;JAMA Dermatol,2015

4. Incidence of multiple vs first cutaneous squamous cell carcinoma on a nationwide scale and estimation of future incidences of cutaneous squamous cell carcinoma.;Tokez;JAMA Dermatol

5. Surveillance, Epidemiology, and End Results Program. SEER cancer statistics review 1975-2017. Accessed September 20, 2020. https://seer.cancer.gov/csr/1975_2017/browse_csr.php

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward personalized skin cancer care: multiple skin cancer development in five cohorts;2024-05-07

2. Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer;Journal of Advanced Research;2024-01

3. Dermatopathology Trends in African Americans: A Retrospective Analysis of Biopsies;The American Journal of Dermatopathology;2023-12-26

4. Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma;Journal for ImmunoTherapy of Cancer;2023-10

5. Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression;JAMA Dermatology;2023-09-01